Protagonist Therapeutics Inc Share Price Nasdaq
Equities
US74366E1029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- PTS | - |
Sales 2024 * | 270M 0 21.19B | Sales 2025 * | 120M 0 9.4B | Capitalization | 1.65B 0 130B |
---|---|---|---|---|---|
Net income 2024 * | 77M - 6.04B | Net income 2025 * | 2M - 157M | EV / Sales 2024 * | 4.48 x |
Net cash position 2024 * | 442M 0 34.66B | Net cash position 2025 * | 677M 0 53.16B | EV / Sales 2025 * | 8.13 x |
P/E ratio 2024 * |
24.4
x | P/E ratio 2025 * |
-28.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
Latest transcript on Protagonist Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 30/11/08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 17/04/22 |
Chief Tech/Sci/R&D Officer | - | 30/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 07/06/17 |
Harold Selick
CHM | Chairman | 69 | 31/01/09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 25/10/23 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |